Skip Navigation


JAC Advance Access originally published online on March 3, 2008
Journal of Antimicrobial Chemotherapy 2008 61(5):1057-1061; doi:10.1093/jac/dkn081
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/5/1057    most recent
dkn081v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Perry, J. D.
Right arrow Articles by Gould, F. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, J. D.
Right arrow Articles by Gould, F. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media

John D. Perry1,*, Larissa Laine2, Susan Hughes1, Audrey Nicholson1, Angela Galloway2 and F. Kate Gould1

1 Department of Microbiology, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK 2 Department of Microbiology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK

Received 11 January 2008; returned 1 February 2008; revised 5 February 2008; accepted 7 February 2008


* Corresponding author. Tel: +44-191-2231226; Fax: +44-191-2231224; E-mail: jdp{at}blueyonder.co.uk

Objectives: To assess the utility of direct plating of whole sputa onto selective media as a means of identifying antimicrobial resistance in strains of Pseudomonas aeruginosa from the sputa of patients with cystic fibrosis (CF).

Methods: A total of 45 sputum samples from CF patients were cultured onto conventional culture media for isolation of P. aeruginosa and were also cultured directly onto Iso-Sensitest agar plates containing each of 10 antimicrobials incorporated at a ‘breakpoint’ concentration. A representative of each colonial type (morphotype) recovered from both routine media and selective media was tested for its susceptibility to 10 antimicrobials using a standard agar dilution MIC technique.

Results: Of the samples shown to contain resistant strains, the proportion (%) detected using routine media and selective media, respectively, was: 42 and 100 for amikacin, 57 and 100 for gentamicin, 54 and 100 for tobramycin, 88 and 77 for aztreonam, 62 and 90 for ceftazidime, 70 and 97 for meropenem, 61 and 100 for piperacillin/tazobactam, 90 and 86 for temocillin, 66 and 100 for ticarcillin/clavulanic acid, and 80 and 90 for ciprofloxacin resistance. The increased rates of isolation on selective media were statistically significant (P < 0.05) for amikacin, gentamicin, tobramycin, meropenem, piperacillin/tazobactam and ticarcillin/clavulanic acid.

Conclusions: For most antimicrobials, selection of colonies from conventional media for antimicrobial susceptibility testing provided a considerable underestimation of resistance in P. aeruginosa. The use of selective media for the culture of whole sputum was effective for the detection of resistant isolates of P. aeruginosa.

Keywords: susceptibility testing , minimum inhibitory concentration , antimicrobial resistance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
L. Vettoretti, P. Plesiat, C. Muller, F. El Garch, G. Phan, I. Attree, A. Ducruix, and C. Llanes
Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1987 - 1997.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. I. Gillham, S. Sundaram, C. R. Laughton, C. S. Haworth, D. Bilton, and J. E. Foweraker
Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis
J. Antimicrob. Chemother., April 1, 2009; 63(4): 728 - 732.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. Foweraker
Recent advances in the microbiology of respiratory tract infection in cystic fibrosis
Br. Med. Bull., March 1, 2009; 89(1): 93 - 110.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.